Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (76)	6/30/2001 1:58:06 AM
From: tuck	Respond to of 897

Anybody think there's a chance in hell we can take advantage of this historic "Glitch?" Will the stock that doubled or more for no reason Friday PM get halved before we can borrow shares or trade options Monday morning? I would say this is likely, but it's sure worth a try. One could assemble a list of shorts and put in limit orders for all of them Sunday night. If you actually get filled on any, you can cancel the rest according to your allocation needs. At least I might try this. Others may have different and better strategies, and I'm all ears. But check things like GLFD, DCGN, RIGL, POZN, and TBIO. Sheeesh! >>Only securities with closing prices or previous closing prices of at least $2 and at least 1000 shares traded are included. Gainers Name Last Chg Pct Transgenomic Inc 19.000 9.100 91.9 Lexent Inc 8.641 3.852 80.4 Western Multiplex 6.869 2.920 73.9 Terayon Commun 6.119 2.398 64.4 Pozen Inc 15.000 5.699 61.3 Stanford Microdev 16.900 6.420 61.3 Metawave Comm 5.189 1.900 57.8 Discovery Labs 5.250 1.801 52.2 divine Inc 2.100 .719 52.1 Docent Inc 10.000 3.391 51.3 Cheers, Tuck

To: Bluegreen who wrote (76)	7/4/2001 9:01:08 AM
From: aknahow	Respond to of 897

Xoma is an enigma for the biotech cognoceti. Many probably avoided even considering it on the way up, out the shared dislike they felt for it. So now that it has gone up few probably have the courage to short it and go on record as having done so. Some on the momentum threads have shorted it and have no fear of admitting to buying or selling a stock. Rather than getting any real information on XOMA from the biotech experts, one is apt to get less than useful comments about the meaning of their offering and claims that silent Calstello, has hyped the stock. It is a bit embarrassing, but not to those who do it apparently. BTW you could probably buy and sell most of the posters I admire. But that's not important in the posting game. You have no following. You insist on posting about XOMA. The in crowd does not follow or post about XOMA. You asked your question on 29 June. I waited before replying, to give anyone a chance to answer.